Common modifiable risk factors in total joint arthroplasty: a 2021 update—diabetes
Preview
Read the full article with your AO login
- Putting numbers to glycemic control
- In the name of better outcomes after arthroplasty
- Is there a better marker for glycemic control than HbA1c?
- Consistency may be more important
- Glycemic control should be part of a multimodal optimization
- Conclusion

Additional AO resources
Access videos, tools, and other assets.
- Videos
- AOF books in Thieme store
- Upcoming events: AO Recon Course finder
Contributing experts
This series of articles was created with the support of the following specialists (in alphabetical order):

Matthew P Abdel
Mayo Clinic
Rochester, United States

Steven MacDonald
University of Western Ontario
London, Canada

Michael A Mont
Rubin Institute for Advanced Orthopedics
Baltimore, United States
This article was compiled by Maio Chen, Senior Project Manager Medical Writing, AO Foundation, Switzerland.
References
- Maradit Kremers H, Schleck CD, Lewallen EA, et al. Diabetes Mellitus and Hyperglycemia and the Risk of Aseptic Loosening in Total Joint Arthroplasty. The Journal of Arthroplasty. 2017 2017/09/01/;32(9, Supplement):S251–S253.
- Marchant MH, Jr., Viens NA, Cook C, et al. The impact of glycemic control and diabetes mellitus on perioperative outcomes after total joint arthroplasty. J Bone Joint Surg Am. 2009 Jul;91(7):1621–1629.
- Shohat N, Goswami K, Tarabichi M, et al. All Patients Should Be Screened for Diabetes Before Total Joint Arthroplasty. J Arthroplasty. 2018 Jul;33(7):2057–2061.
- Adams AL, Paxton EW, Wang JQ, et al. Surgical outcomes of total knee replacement according to diabetes status and glycemic control, 2001 to 2009. J Bone Joint Surg Am. 2013 Mar 20;95(6):481–487.
- Ojemolon PE, Shaka H, Edigin E, et al. Impact of Diabetes Mellitus on Outcomes of Patients With Knee Osteoarthritis Who Underwent Knee Arthroplasty: An Analysis of the Nationwide Inpatient Sample. Cureus. 2020 Jun 29;12(6):e8902.
- Giori NJ, Ellerbe LS, Bowe T, et al. Many diabetic total joint arthroplasty candidates are unable to achieve a preoperative hemoglobin A1c goal of 7% or less. J Bone Joint Surg Am. 2014 Mar 19;96(6):500–504.
- van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001 Nov 8;345(19):1359–1367.
- Bolognesi MP, Marchant MH, Jr., Viens NA, et al. The impact of diabetes on perioperative patient outcomes after total hip and total knee arthroplasty in the United States. J Arthroplasty. 2008 Sep;23(6 Suppl 1):92–98.
- George J, Piuzzi NS, Jawad MM, et al. Reliability of International Classification of Diseases, Ninth Edition, Codes to Detect Morbid Obesity in Patients Undergoing Total Hip Arthroplasty. J Arthroplasty. 2018 Sep;33(9):2770–2773.
- Association AD. 6. Glycemic Targets: Standards of Medical Care in Diabetes—2021. Diabetes Care. 2021;44(Supplement 1):S73–S84.
- Shohat N, Tarabichi M, Tischler EH, et al. Serum Fructosamine: A Simple and Inexpensive Test for Assessing Preoperative Glycemic Control. J Bone Joint Surg Am. 2017 Nov 15;99(22):1900–1907.
- Jämsen E, Nevalainen P, Kalliovalkama J, et al. Preoperative hyperglycemia predicts infected total knee replacement. Eur J Intern Med. 2010 Jun;21(3):196–201.
- Iorio R, Williams KM, Marcantonio AJ, et al. Diabetes mellitus, hemoglobin A1C, and the incidence of total joint arthroplasty infection. J Arthroplasty. 2012 May;27(5):726–729.e721.
- Harris AH, Bowe TR, Gupta S, et al. Hemoglobin A1C as a marker for surgical risk in diabetic patients undergoing total joint arthroplasty. J Arthroplasty. 2013 Sep;28(8 Suppl):25–29.
- Han HS, Kang SB. Relations between long-term glycemic control and postoperative wound and infectious complications after total knee arthroplasty in type 2 diabetics. Clin Orthop Surg. 2013 Jun;5(2):118–123.
- Stryker LS, Abdel MP, Morrey ME, et al. Elevated postoperative blood glucose and preoperative hemoglobin A1C are associated with increased wound complications following total joint arthroplasty. J Bone Joint Surg Am. 2013 May 1;95(9):808–814, s801–802.
- Hwang JS, Kim SJ, Bamne AB, et al. Do glycemic markers predict occurrence of complications after total knee arthroplasty in patients with diabetes? Clin Orthop Relat Res. 2015 May;473(5):1726–1731.
- Chrastil J, Anderson MB, Stevens V, et al. Is Hemoglobin A1c or Perioperative Hyperglycemia Predictive of Periprosthetic Joint Infection or Death Following Primary Total Joint Arthroplasty? J Arthroplasty. 2015 Jul;30(7):1197–1202.
- Cancienne JM, Werner BC, Browne JA. Is There a Threshold Value of Hemoglobin A1c That Predicts Risk of Infection Following Primary Total Hip Arthroplasty? J Arthroplasty. 2017 Sep;32(9s):S236–S240.
- Citak M, Toussaint B, Abdelaziz H, et al. Elevated HbA1c is not a risk factor for wound complications following total joint arthroplasty: a prospective study. Hip Int. 2020 Sep;30(1_suppl):19–25.
- Shohat N, Restrepo C, Allierezaie A, et al. Increased Postoperative Glucose Variability Is Associated with Adverse Outcomes Following Total Joint Arthroplasty. J Bone Joint Surg Am. 2018 Jul 5;100(13):1110–1117.
- Shohat N, Tarabichi M, Tan TL, et al. 2019 John Insall Award: Fructosamine is a better glycaemic marker compared with glycated haemoglobin (HbA1C) in predicting adverse outcomes following total knee arthroplasty: a prospective multicentre study. Bone Joint J. 2019 Jul;101-b(7_Supple_C):3–9.
- Jämsen E, Nevalainen PI, Eskelinen A, et al. Risk factors for perioperative hyperglycemia in primary hip and knee replacements. Acta Orthop. 2015 Apr;86(2):175–182.